Isradipine
Brand Names: DynaCirc
Methodology & AI Transparency ⓘ
Isradipine Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Indications and usage: Hypertension Isradipine is indicated in the management of hypertension.
- 2 Real-world patient consensus: Real-world cohort score of 76% across 13 de-identified Isradipine entries.
- 3 Typical cash cost range: Dispensing cost comparison spans $41.49 mail/discount cash up to $101.65 uninsured retail (federal NADAC $1.1368).
- 4 Top reported side effects / signs: Leading openFDA/SPL adverse events for Isradipine: dizziness (8%), headache (6.3%), fatigue (4.7%).
Ask our AI Specialists anything about Isradipine
Isradipine Mechanism, CYP450 Pathways & DailyMed Monograph
Indications and usage: Hypertension Isradipine is indicated in the management of hypertension. It may be used alone or concurrently with thiazide-type diuretics.
Mechanism of Action Isradipine is a dihydropyridine calcium channel blocker. It binds to calcium channels with high affinity and specificity and inhibits calcium flux into cardiac and smooth muscle. The effects observed in mechanistic experiments in vitro and studied in intact animals and man are compatible with this mechanism of action and are typical of the class.
Following administration (5 mg/1 Capsule), Isradipine achieves ~15% systemic bioavailability (Isradipine) bioavailability and cmax attained 2–3 hours post-administration of isradipine onset, governed by a Elimination kinetics span 11 to 24 hours per Isradipine clinical pharmacology terminal half-life through systemic clearance of isradipine integrates hepatic phase ii conjugation with renal filtration.
Before initiating Isradipine at 5 mg/1 Capsule, clinical safety checklists rule out contraindications isradipine is contraindicated in individuals who have shown hypersensitivity to any of the ingredients in the formulation.; previous anaphylactoid or exfoliative reaction attributed to isradipine. Logged tolerability patterns center on dizziness (8% of reports), headache (6.3% of reports), fatigue (4.7% of reports).
Staggering Isradipine apart from antacid or iron products prevents insoluble gastrointestinal complexation.
Verify medication reconciliation lists so Isradipine is not inadvertently duplicated with another dihydropyridine calcium channel blocker.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- CONTRAINDICATIONS Isradipine is contraindicated in individuals who have shown hypersensitivity to any of the ingredients in the formulation.
- Previous anaphylactoid or exfoliative reaction attributed to Isradipine
Logged Side-Effect Incidence (13 Reports)
Isradipine Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Isradipine)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Isradipine plasma how the body absorbs the medicine and exposure-response in In this clinical trial, higher isradipine plasma exposure did not affect clinical assessment measures of PD severity but modestly decreased cumulative levodopa equivalent dose and the time needed for antiparkinson treatment... Annals of clinical and translational neurology • 2021-03-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 33460320 ↗ |
Isradipine Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $1.1368/unit (~$34.10/30u) | Wholesale baseline |
| Mark Cuban Cost Plus Drugs (Mail-Order Generic) | Public Wholesale Price List (NADAC + 15% + pharmacy fee) | $41.49 / mo | Formulary listing ↗ |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $101.65 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 13 Anonymous DotMD Community Micro-Logs | $47.71 / mo | View logs ↓ |
| Sesame Direct Cash-Pay Prescriber Network (Licensed Telehealth Cash Program) | State-licensed clinician review • ~1d mail fulfillment | $29.00 consult | Program details |
Isradipine Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Isradipine RxNorm Concept ID | 197848 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $1.1368 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $101.65 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $41.49 / mo (Cost Plus Drugs) | Mark Cuban Cost Plus Public API |
| Real-World Patient Consensus | 76.00% Worth It (13 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Isradipine Patient Community, Cohort Filters & Dosage Logs
Cross-verified Isradipine (dihydropyridine calcium channel blocker) monograph synthesizing RxNorm 197848, openFDA FAERS signals, and $41.49–$101.65 cash benchmarks.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Isradipine community threads and patient logs by age, biological sex, dosage, and treatment duration.